Joseph Amann is an associate at Morgan Stanley in New York. He specializes in firmwide market risk and covers all securitized products.
Prior to Morgan Stanley, Amann worked as an analyst at a boutique consulting firm, where he advised on CMBS valuations, bank merger due-diligence, and private equity risk management.
Amann, a graduate of the University of Delaware, is a Carnegie Council Trustee, a member of its investment committee, and on the CNL Steering Committee. He also sits on the executive committees for the Leukemia Lymphoma and the NYC Board of Directors for his alma mater.
Last Updated: Jun 06, 2012
